New screening strategy introduced to develop possible drug candidates
Washington: Scientists have developed a new drug-discovery strategy, which will help them in rapidly selecting chemical compounds that will have a desired effect on cells.
Researchers from the Scripps Research Institute (TSRI) has also tried to highlight how these compounds will work.
Scientists have identified a compound that shows promise for treating obesity-linked diabetes by using the innovative technique, and were able to identify the fat-cell enzyme that the compound inhibits.
The strategy uses the increasing availability of special libraries of related compounds that act as inhibitors of entire enzyme classes.
The researchers have used a set of compounds, recently synthesized by Cravatt's laboratory, that tend to inhibit serine hydrolases.
The researchers have been able to use combined phenotypic screening and target-identification approach to quickly discover, characterize and carry out preclinical tests of a potential new drug for obesity-linked diabetes.
The study was published an advance online issue of Nature Chemical Biology.
More from India
More from World
More from Sports
More from Entertaiment
- Jamaat-e-Islami chief announces Rs 100 cr reward for PM Modi's arrest
- Zee Media exclusive interview with victim of Uber molestation
- Maggi samples found unsafe: Delhi government
- DNA: Analysis of Vijay Mallya's 'fund transfer formula'
- IMD forecasts 'deficient' Monsoon, drought-like conditions expected
- Was asked to call Sunanda Pushkar’s death `natural`: AIIMS doctor
- Maggi row: Delhi registers case against Nestle, Kerala withdraws stock from govt stores
- Rahul Gandhi hails BR Ambedkar, takes potshot at Modi-led NDA govt over IIT Madras row
- From being the ‘Dabangg’ girl to ‘Akira’ - Sonakshi Sinha’s journey so far
- China ship carrying 458 on board sinks in Yangtze River: Five dead, hundreds missing